Galadlas, Sarah Jane D.
HRN: 05-17-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFUROXIME 500MG (TAB)
04/02/2024
04/08/2024
PO
1 Tab
BID
Thickly Msaf
Checking Final Appropriateness
04/02/2024
METRONIDAZOLE 500MG (TAB)
04/02/2024
04/08/2024
PO
1 Tab
TID
Thickly Msaf
Checking Final Appropriateness